BVBiomedical Ltd. is currently looking for partnership opportunities to conduct a phase 2a clinical trial using relaxin to treat MS. The clinical trial is in collaboration with the MS Unit at University College London. For additional information on our programs and partnering contact us.
@BVBiomedical Ltd. 2020 Working to conquer multiple sclerosis, concussion and TBI
BVBiomed Ltd. was founded in 2012. Building on our novel therapuetics for neurodegenerative diseases. We are a drug discovery company.